Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.
作者信息
Heyes J, Catherall E J, Cockburn A
出版信息
Cancer Chemother Rep. 1973 Sep-Oct;57(3):263-8.
PMID:4751253
Abstract
摘要
相似文献
1
2
5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
Eur J Cancer (1965). 1972 Feb;8(1):85-92. doi: 10.1016/0014-2964(72)90087-4.
3
Antimetastatic effect of 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole.4-乙氧羰基-5-(3,3-二甲基-1-三氮烯基)-2-甲基咪唑的抗转移作用
J Natl Cancer Inst. 1974 Jul;53(1):279-80. doi: 10.1093/jnci/53.1.279.
4
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.
Cancer Chemother Rep. 1972 Oct;56(5):667-70.
5
Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).使用抗肿瘤药物5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）的临床试验。
Cancer Chemother Rep. 1970 Apr;54(2):119-24.
7
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）用于胃肠道癌患者。
Cancer Chemother Rep. 1970 Dec;54(6):471-3.
8
9
Antitumor activity of DTIC (NSC-45388) in animals.氮烯咪胺（NSC - 45388）在动物体内的抗肿瘤活性。
Cancer Treat Rep. 1976 Feb;60(2):135-40.
10
Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.
Cancer. 1972 Sep;30(3):654-9. doi: 10.1002/1097-0142(197209)30:3<654::aid-cncr2820300312>3.0.co;2-x.
Zotero 插件